SCHEMBL6540475

SCHEMBL6540475

COc1ccc(-c2nc(C(=O)N3CCCCC3)oc2-c2ccc(OCCNC(N)=O)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 1/20 0.44
HPGD P15428 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
PTGS2 P35354 2/20 0.42
CNR1 P21554 2/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
ACHE P22303 1/20 0.39
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39
MAPT P10636 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KMT2A Q03164 1/20 0.38
GRM5 P41594 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6540433 0.92 ALDH1A1 (0.44) ALDH1A1LMNATSHRHPGDSMN1; SMN2
SCHEMBL6539344 0.91 HPGD (0.42) ALDH1A1LMNATSHRHPGDSMN1; SMN2
SCHEMBL6539405 0.88 HPGD (0.49) ALDH1A1LMNAHPGDSMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL6539318 0.87 HPGD (0.47) ALDH1A1LMNAHPGDSMN1; SMN2NPC1
SCHEMBL6255678 0.87 HPGD (0.43) ALDH1A1LMNATSHRHPGDSMN1; SMN2
SCHEMBL6539699 0.83 HPGD (0.43) ALDH1A1LMNATSHRHPGDSMN1; SMN2
SCHEMBL6233246 0.82 RAB9A (0.50) ALDH1A1LMNATSHRHPGDSMN1; SMN2
SCHEMBL6539856 0.81 MTNR1A (0.48) ALDH1A1LMNAHPGDSMN1; SMN2NPC1
SCHEMBL6252437 0.81 MTNR1A (0.42) ALDH1A1LMNAHPGDSMN1; SMN2NPC1
SCHEMBL6539351 0.81 RAB9A (0.53) ALDH1A1LMNAHPGDSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 ALDH1A1 163/4885LMNA 2620/4885TSHR 4439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.